We showed that PIP4K2A suppresses human GBM growth in vitro and in vivo, stem-like characteristics, and PI3K/AKT signaling through Cbl-mediated p85/p110 PI3K complex degradation in PTEN-deficient tumors. This evidence concerns the gene PIK3R2 and glioblastoma.